Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030723

Director sold 273 shares at $46.06 ($12,574)

  • Director acquired 545 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Carol Giltner Director 2018-05-15 Option exercise +545 111,465 D
Gallagher Carol Giltner Director 2018-05-16 Sale −273 $46.06 $12,574 111,192 D
Derivatives
Gallagher Carol Giltner Director 2018-05-15 Option exercise · Restricted Stock Units −545 0 D
Open-market sales · 273 sh · avg $46.06 · $12,574
Loading xslF345X03/doc4.xml…